Ticker Details
Olema Pharmaceuticals, Inc.
IPO Date:	November 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$935.35M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.56 | 4.39%
Avg Daily Range (30 D):	$0.34 | 2.97%
Avg Daily Range (90 D):	$0.36 | 2.98%

Institutional Daily Volume
Avg Daily Volume:	.67M
Avg Daily Volume (30 D):	.8M
Avg Daily Volume (90 D):	1.03M

Trade Size
Avg Trade Size (Sh.):	83
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	65

Institutional Trades
Total Institutional Trades:	1,327
Avg Institutional Trade:	$1.97M
Avg Institutional Trade (30 D):	$1.39M
Avg Institutional Trade (90 D):	$1.9M
Avg Institutional Trade Volume:	.14M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.62M
Avg Closing Trade (30 D):	$1.75M
Avg Closing Trade (90 D):	$2.43M
Avg Closing Volume:	181.2K

News

May 26, 2026 @ 11:00 AM Olema Oncology Announces Clinical Trial Collaborat... Source: Na

May 21, 2026 @ 9:00 PM Olema Oncology Announces Encouraging Initial Clini... Source: Olema Oncology

May 20, 2026 @ 5:00 PM ESR1-Mutated Metastatic Breast Cancer Market Expec... Source: Delveinsight

Mar 16, 2026 @ 11:00 AM Olema Oncology Reports Fourth Quarter and Full Yea... Source: Na

Mar 9, 2026 @ 5:57 PM Olema Pharmaceuticals, Inc. Investigated on Behalf... Source: Business Wire

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-2.13	$-.61	$-.52
Diluted EPS	$-2.13	$-.61	$-.52
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-204.57M	$-63.2M	$-53.09M
Operating Income / Loss	$-221.13M	$-67.18M	$-57.99M
Cost of Revenue
Net Cash Flow	$-3.87M	$-3.95M	$4.25M
PE Ratio